MAPT and Alzheimer disease: Based on these studies, it can be speculated that Tau/TDP-43 co-condensates may further develop into heterotypic Tau/TDP-43 co-aggregates, similar to those observed in AD+ patients (Fig. EV5C and Tomé et al, 2021).